Perrigo (PRGO) Change in Receivables (2013 - 2026)
Perrigo (PRGO) posted quarterly Change in Receivables of $92.5 million for Q1 2026, up 41.87% year-over-year from $65.2 million in Q1 2025, and up 454.41% quarter-over-quarter from -$26.1 million in Q4 2025.
Perrigo (PRGO) Change in Receivables (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Change in Receivables for 14 consecutive years, with $92.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables rose 41.87% year-over-year to $92.5 million; the TTM figure through Mar 2026 stood at -$3.4 million (down 113.93% YoY), while the FY2025 annual figure was -$30.7 million, down 376.58% from the prior year.
- Change in Receivables grew to $92.5 million in Q1 2026 per PRGO's latest filing, from -$26.1 million in the prior quarter.
- Across five years, Change in Receivables topped out at $92.5 million in Q1 2026 and bottomed at -$59.3 million in Q2 2025.
- Historically, Change in Receivables has averaged $7.6 million across 5 years, with a median of -$1.9 million in 2023.
- On a YoY basis, Change in Receivables climbed as much as 2836.84% in 2024 and fell as far as 331.11% in 2024.
- Perrigo's Change in Receivables stood at -$38.7 million in 2022, then jumped by 65.12% to -$13.5 million in 2023, then sank by 331.11% to -$58.2 million in 2024, then soared by 55.15% to -$26.1 million in 2025, then soared by 454.41% to $92.5 million in 2026.
- Business Quant data shows PRGO's Change in Receivables at $92.5 million in Q1 2026, -$26.1 million in Q4 2025, and -$10.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 9.80 Mn |
| Jun 27, 2026 | 9.80 Mn |
| Mar 28, 2026 | 92.50 Mn |
| Mar 28, 2026 | 92.50 Mn |
| Dec 31, 2025 | -26.10 Mn |
| Dec 31, 2025 | -26.10 Mn |
| Sep 27, 2025 | -10.50 Mn |
| Sep 27, 2025 | -10.50 Mn |
| Jun 28, 2025 | -59.30 Mn |
| Jun 28, 2025 | -59.30 Mn |
| Mar 29, 2025 | 65.20 Mn |
| Mar 29, 2025 | 65.20 Mn |
| Dec 31, 2024 | -58.20 Mn |
| Dec 31, 2024 | -58.20 Mn |
| Sep 28, 2024 | 52.00 Mn |
| Sep 28, 2024 | 52.00 Mn |
| Jun 29, 2024 | -34.60 Mn |
| Jun 29, 2024 | -34.60 Mn |
| Mar 30, 2024 | 51.90 Mn |
| Mar 30, 2024 | 51.90 Mn |